These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17204315)

  • 21. Birch pollen immunotherapy inhibits anaphylaxis to the cross-reactive apple allergen Mal d 1 in mice.
    Utsch L; Logiantara A; Wallner M; Hofer H; van Ree R; van Rijt LS
    Clin Exp Allergy; 2016 Nov; 46(11):1474-1483. PubMed ID: 27376790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal digestion of Bet v 1-homologous food allergens destroys their mediator-releasing, but not T cell-activating, capacity.
    Schimek EM; Zwölfer B; Briza P; Jahn-Schmid B; Vogel L; Vieths S; Ebner C; Bohle B
    J Allergy Clin Immunol; 2005 Dec; 116(6):1327-33. PubMed ID: 16337467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test.
    Erdmann SM; Sachs B; Schmidt A; Merk HF; Scheiner O; Moll-Slodowy S; Sauer I; Kwiecien R; Maderegger B; Hoffmann-Sommergruber K
    Int Arch Allergy Immunol; 2005 Mar; 136(3):230-8. PubMed ID: 15713985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination with genetically modified birch pollen allergens: immune and clinical effects on oral allergy syndrome.
    Niederberger V; Reisinger J; Valent P; Krauth MT; Pauli G; van Hage M; Cromwell O; Horak F; Valenta R
    J Allergy Clin Immunol; 2007 Apr; 119(4):1013-6. PubMed ID: 17292956
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of birch pollen SIT on apple allergy: a matter of dosage?
    Asero R
    Allergy; 2004 Dec; 59(12):1269-71. PubMed ID: 15507094
    [No Abstract]   [Full Text] [Related]  

  • 26. Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.
    Hofmann C; Scheurer S; Rost K; Graulich E; Jamin A; Foetisch K; Saloga J; Vieths S; Steinbrink K; Adler HS
    J Allergy Clin Immunol; 2013 May; 131(5):1384-92.e6. PubMed ID: 23246018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen.
    Son DY; Scheurer S; Hoffmann A; Haustein D; Vieths S
    Eur J Nutr; 1999 Aug; 38(4):201-15. PubMed ID: 10502033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level.
    Bohle B; Radakovics A; Jahn-Schmid B; Hoffmann-Sommergruber K; Fischer GF; Ebner C
    Eur J Immunol; 2003 Dec; 33(12):3303-10. PubMed ID: 14635038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular composition and biological activity of commercial birch pollen allergen extracts.
    Focke M; Marth K; Valenta R
    Eur J Clin Invest; 2009 May; 39(5):429-36. PubMed ID: 19302561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant Mal d 1 is a reliable diagnostic tool for birch pollen allergen-associated apple allergy.
    Kollmann D; Geroldinger-Simic M; Kinaciyan T; Huber H; Ebner C; Lidholm J; Bohle B
    J Allergy Clin Immunol; 2013 Oct; 132(4):1008-10. PubMed ID: 23810767
    [No Abstract]   [Full Text] [Related]  

  • 31. Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen.
    Larenas-Linnemann D
    Curr Opin Investig Drugs; 2010 May; 11(5):586-96. PubMed ID: 20419605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublingual immunotherapy in peach allergy: monitoring molecular sensitizations and reactivity to apple fruit and Platanus pollen.
    García BE; González-Mancebo E; Barber D; Martín S; Tabar AI; Díaz de Durana AM; Garrido-Fernández S; Salcedo G; Rico P; Fernández-Rivas M
    J Investig Allergol Clin Immunol; 2010; 20(6):514-20. PubMed ID: 21243936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Search for low-allergenic apple cultivars for birch-pollen-allergic patients: is there a correlation between in vitro assays and patient response?
    Asero R; Marzban G; Martinelli A; Zaccarini M; Machado ML
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):94-8. PubMed ID: 16752695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
    Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
    J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy.
    Mittag D; Akkerdaas J; Ballmer-Weber BK; Vogel L; Wensing M; Becker WM; Koppelman SJ; Knulst AC; Helbling A; Hefle SL; Van Ree R; Vieths S
    J Allergy Clin Immunol; 2004 Dec; 114(6):1410-7. PubMed ID: 15577846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between Bet v 1 and Bet v 2 specific IgE and food allergy in children with grass pollen respiratory allergy.
    Ricci G; Righetti F; Menna G; Bellini F; Miniaci A; Masi M
    Mol Immunol; 2005 Jun; 42(10):1251-7. PubMed ID: 15829314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of amino acid positions crucial for IgE-binding epitopes of the major apple (Malus domestica) allergen, Mal d 1.
    Ma Y; Gadermaier G; Bohle B; Bolhaar S; Knulst A; Markovic-Housley Z; Breiteneder H; Briza P; Hoffmann-Sommergruber K; Ferreira F
    Int Arch Allergy Immunol; 2006; 139(1):53-62. PubMed ID: 16293967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
    Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
    J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naturally occurring hypoallergenic Bet v 1 isoforms fail to induce IgE responses in individuals with birch pollen allergy.
    Wagner S; Radauer C; Bublin M; Hoffmann-Sommergruber K; Kopp T; Greisenegger EK; Vogel L; Vieths S; Scheiner O; Breiteneder H
    J Allergy Clin Immunol; 2008 Jan; 121(1):246-52. PubMed ID: 17889932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant birch allergens (Bet v 1 and Bet v 2) and the oral allergy syndrome in patients allergic to birch pollen.
    De Amici M; Mosca M; Vignini M; Quaglini S; Moratti R
    Ann Allergy Asthma Immunol; 2003 Nov; 91(5):490-2. PubMed ID: 14692434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.